secwatch / observer
8-K filed June 14, 2023, 7:59 PM ET CIK 0001015155
regulatory confidence high sentiment negative materiality 0.70

CHARLES & COLVARD LTD: Nasdaq/NYSE listing notice — Charles & Colvard receives Nasdaq bid price deficiency notice; 180-day cure period

CHARLES & COLVARD LTD

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

CHARLES & COLVARD LTD received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
June 12, 2023, Charles & Colvard, Ltd. (the “Company”) received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company’s common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until December 11, 2023, to reg
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001104659-23-071201
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.